The PREVENT Trial: How the Largest Randomized Trial to Assess Lymphedema Prevention Will Impact Patient Care Today and for Years to Come

Featured Faculty
Chirag Shah, MD, Co-Director Comprehensive Breast Program, Director of Breast Cancer Radiation Oncology and Director of Clinical Research, Department of Radiation Oncology, Cleveland Clinic
Louise Koelmeyer, PhD, Occupational Therapist & Lymphoedema Therapist, Director & Associate Professor in the Australian Lymphoedema Education, Research and Treatment (ALERT) program at Macquarie University

VIEW RECORDING

Overview

New Data! With the recent quality-of-life analysis publication, PREVENT, the largest randomized trial to assess lymphedema prevention,
has generated eight manuscripts that bring novel data and insights into the care of secondary lymphedema patients. Join PREVENT
co-investigators Chirag Shah, MD and Louise Koelmeyer, PhD, as they review the comprehensive findings from PREVENT and provide
their perspective on its impact on patient care.

Learning Objectives

Understand the data supporting PREVENT’s protocol including the L-Dex trigger of +6.5 and compression therapy
Evaluate new insights about the care of lymphedema patients and who is at risk
Hear expert perspectives on the changing landscape of lymphedema care

VIEW RECORDING

Featured Faculty

Chirag Shah, MD

Co-Director Comprehensive Breast Program, Director of Breast Cancer Radiation Oncology and Director of
Clinical Research, Department of Radiation Oncology, Cleveland Clinic

Dr. Shah received his bachelor’s degree from Youngstown State University and his Medical degree from Northeast Ohio Medical University. He completed his internship, and residency at William Beaumont Hospital from 2007 to 2012 and joined the Cleveland Clinic Staff in 2015 where he is an associate professor in the department of radiation oncology. Dr. Shah serves as a reviewer for various medical journals and is a member of various medical societies. His primary research interests are breast cancer, sarcoma, and innovative radiation treatment schedules as well as lymphedema. He has participated in numerous in-house, pharmaceutical and cooperative group trials.

Louise Koelmeyer, PhD

Occupational Therapist & Lymphoedema Therapist, Director & Associate Professor in the Australian
Lymphoedema Education, Research and Treatment (ALERT) program at Macquarie University

Louise Koelmeyer, PhD has over 28 years of clinical experience in both public and private hospital and clinic settings specializing in breast cancer rehabilitation and lymphoedema management in all areas of assessment, education, early detection and treatment. As Lymphoedema Program Director & Associate Professor in the Australian Lymphoedema Education, Research and Treatment (ALERT) program at Macquarie University, Louise is involved in strategically managing and developing the education, research and treatment arms of the innovative multidisciplinary program. Louise’s clinical interests and expertise are in developing a therapeutic relationship with individuals and personalizing treatment programs that support the patient’s needs and goals to achieve positive outcomes.

Learn More About SOZO^®

SOZO uses ImpediMed’s BIS technology to measure and track critical information about the human body to aid clinicians in managing chronic disease and maximizing patient health. SOZO is non-invasive, fast, and easy to use. Results from the 30-second test* are available immediately providing proactive patient care including early detection of disease progression, treatment monitoring, and patient education.

*As tested on Android